Four things you need to know: 1. A team of researchers led by Michael Bretthauer, MD, PhD, a gastroenterologist at the University of Oslo in Norway, conducted the study at six Norwegian hospitals ...

The big breakthrough in C. diff treatment was reported by the New England Journal of Medicine in 2013. Researchers in the Netherlands conducted a randomized controlled trial comparing the ...

Q: I was sick for months with debilitating pain, extreme weight loss, fatigue and loss of appetite. I was diagnosed with C. diff related to an abdominal surgery. I’m being treated with antibiotics, ...

Dear Doctors: I was sick for months with debilitating pain, extreme weight loss, fatigue and loss of appetite. I was diagnosed with C. diff related to an abdominal surgery. I’m being treated with ...

The FDA approved the first fecal transplant therapy, Rebyota, for people with ongoing Clostridioides difficile, ABC News reported Nov. 30. Rebyota is a therapy manufactured by stool donations that are ...

A new Cochrane Review led by an Upstate Medical University professor has found that, compared with standard antibiotic treatment, stool transplantation can increase the number of people recovering ...

WASHINGTON (AP) — U.S. officials have approved the first pharmaceutical-grade version of the so-called fecal transplant procedures that doctors have increasingly used against hard-to-treat intestinal ...

A new study from the University of Birmingham has shown that Faecal Microbiota Transplants (FMT) are highly successful in treating patients with Clostridioides difficile (C.diff) infection. Published ...

A fecal microbiota transplant (FMT) not only cured a case of Clostridium difficile (C. diff) infection in a 66 year old man; it eliminated populations of multi-drug resistant organisms both in the ...

Dear Doctors: I was sick for months with debilitating pain, extreme weight loss, fatigue and loss of appetite. I was diagnosed with C. diff related to an abdominal surgery. I’m being treated with ...